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2Supplementary Figure 1. Additional examples of phosphorylated SGK1 expression in mid-
secretory endometrium from individuals with recurrent pregnancy loss (RPL), infertility (INF), 
or fertile controls (FER). Each micrograph represents a different subject biopsy. (Scale Bar: 100 

3Supplementary Figure 2. Semi-quantification of total (t-) and phosphorylated (p-) SGK1
levels in total tissue lysates from mid-secretory endometrial biopsies from individuals with 
recurrent pregnancy loss (RPL, n=6) and unexplained infertility (INF, n=6). The results of the 
Western blot analysis, presented in Fig. 1C, were analyzed using ImageJ software 
(http://rsbweb.nih.gov/ij/). Statistical significance was determined using students t-test, *** P <
0.001. Data are presented as means (± SEM).
4Supplementary Figure 3. Immunostaining for phosphorylated SGK1 expression during the 
putative window of endometrial receptivity in the mouse uterus. (a) Low ( 100; upper panels) 
and high ( 400; lower panels) magnification of immunostained tissue sections at 3.5 dpc (pre-
receptive), 4.0 dpc (early receptive) and 5.0 dpc (refractory). The decline in phosphorylated 
SGK1 levels was particularly striking in the luminal epithelium. (b) Low SGK1 expression in 
the endometrial luminal epithelium at the site of an implanting embryo (arrows) at 4.5 dpc. Note 
that SGK1 immunoreactivity was detectable in the embryo at this stage of development, 
although staining intensity was invariably low. (Magnification  400).
5Supplementary Figure 4. Expression of a constitutively active SGK1 mutant in the luminal 
epithelium perturbs endometrial osmoregulation. (a) Morphometric analysis of the average (± 
SEM) cellular width of luminal endometrial epithelial cells and glandular area in control and
S422DSGK1-transfected animals. Compared to non pregnant animals transfected with the control 
plasmid, expression of the constitutive active SGK1 mutant resulted by 8.5 dpc in a decrease in 
the distance between luminal epithelial cells and total endometrial glandular area. (b) Total 
protein lysates from snap-frozen uterine samples from non pregnant uteri (8.5 dpc), transfected 
first either with a control plasmid or with S422DSGK1pIRES2eGFP, an expression vector that 
encodes both enhanced green fluorescent protein (eGFP) and a constitutively active SGK1 
mutant, were subjected to Western blot analysis and immunoprobed with antibodies specific to 
eGFP, phosphorylated (p-) SGK1, NEDD4-2, and -ENaC. The results not only confirm the 
efficacy of in vivo expression but also demonstrate that overexpressed S422DSGK1 is functionally 
active. Statistical significance was determined using students t-test, *** P < 0.001.
6Supplementary Figure 5. Analysis of endometrial receptivity genes. Expression of bone 
morphogenetic protein 2 (Bmp2), Indian hedgehog (Ihh), and wingless-related MMTV
integration site 4 (Wnt4) transcripts was determined in uterine horns 3 days after transfection 
(4.5 dpc) with a control plasmid (pcDNA3.1; n=6) or an expression vector that encodes the 
constitutively active mutant S422DSGK1 (n=8). In addition, expression levels were compared to 
those in wild type female animals (n=4) that were not mated. Statistical significance was 
determined using students t-test, * P < 0.05. Data are presented as means (± SEM).
7Supplementary Figure 6. SGK1 upregulates the expression of ENaC and cystic fibrosis 
transmembrane conductance regulator (CFTR) in the mouse uterus. Expression of -ENaC and 
CFTR transcripts was determined in uterine horns 3 days after transfection (4.5 dpc) with a 
control plasmid (pcDNA3.1; n=6) or an expression vector that encodes the constitutively active 
mutant S422DSGK1 (n=6; upper panels). Data are presented as means (± SEM). Parallel tissue 
sections were processed for Western blot analysis and immunoprobed for -ENaC and CFTR
(lower panels). -ACTIN served as a loading control. Statistical significance was determined 
using students t-test, ** P < 0.01; *** P < 0.001.
8Supplementary Figure 7. Morphological assessment of implantation sites in Sgk1–/– mice. 
Hematoxylin & eosin stained longitudinal tissue sections were obtained at 8.5 dpc from wild
type (WT) female mice crossed with Sgk1–/– males (left panels) and Sgk1–/– females with WT
males (right panels). In WT females, all embryos had differentiated into endoderm, mesoderm 
and ectoderm, with an amniotic cavity, amnion and chorion present, and an ectoplacental cone. 
Although orientation varies, the implantation sites appeared healthy. Based on serial 5 μm 
sections, the average implantation site in WT females measured approximately 325 μm in 
width. In pregnant Sgk1–/– females, some embryos had differentiated almost as well as in WT
females but most were small and underdeveloped. Based on serial 5 μm sections, implantation 
sites in Sgk1–/– females measured between 150 - 210 μm in across. In addition to an occasional 
twin pregnancy (middle right panel), several implantation sites were characterized by local 
bleeding (arrows), neutrophil aggregates, or both. (	
).
9Supplementary Figure 8. Increased apoptosis at the feto-maternal interface in pregnant Sgk1–/–
mice. (a) Tissue sections, obtained at 8.5 dpc from WT female mice crossed with Sgk1–/– males 
(left panels) and Sgk1–/– females with WT males (right panels), were subjected to terminal 
transferase-mediated dUTP nick end-labeling (TUNEL; upper panels) and activated Caspase-3
staining (lower panels). The results indicate that the normal apoptotic responses at the feto-
maternal boundaries are enhanced in pregnant Sgk1–/– mice, especially at the site of bleeding 
(arrows). Insert in the top left panel shows positive TUNEL labelling in the mouse mammary 
gland (positive control). (Scale ba). (b) The overall increase in uterine cell death was 
confirmed by Western blot analysis of total uterine protein lysates for the expression of cleaved 
PARP1.
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Supplementary Figure 9. Induction of SGK1 transcripts in primary decidualizing HESCs 
established from control subjects. The control group consisted of women suffering from 
conception delay because of either tubo-ovarian (n=6), male factor (n=3), or unexplained 
infertility (n=3). RTQ-PCR was used to measure the expression levels of SGK1 transcripts in 
undifferentiated cultures (0 d) and in cultures decidualized with 8-bromo-cAMP (cAMP) and 
medroxyprogesterone acetate (MPA) for the indicated time-points. Transcript levels were 
normalized to the housekeeping gene L19 and expressed in arbitrary units (AU). The SGK1
transcript levels between the clinical groups did not differ significantly (P >0.05) in 
undifferentiated or decidualizing HESCs (Note: logarithmic scale). Data are presented as means 
(± SEM).
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Supplementary Figure 10. SGK1 knockdown in HESCs. Primary HESCs cultured on chamber 
slides were transfected with either non targeting (NT) or SGK1 siRNA, decidualized for 72 h
with cAMP and MPA, loaded with MitoTracker dye (red) and stained for SGK1 expression 
(green). The nuclei were visualized with DAPI (blue). Note that the typical transformation of 
spindle-like fibroblast to more rounded decidual cells, with larger nuclei and more abundant 
cytoplasm, was maintained upon SGK1 knockdown. (Scale bar: 25 m).
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Supplementary Figure 11. SGK1 deficiency impairs antioxidant defences in decidual cells. (a)
RTQ-PCR was used to measure the expression levels of SOD2, TXN, PRDX2 and GLRX
transcripts in primary HESC cultures first transfected with non targeting (NT) or SGK1 siRNA 
and then decidualized for 4 d (left panel). (b) Expression levels were also determined in 
undifferentiated and decidualizing primary HESC cultures established from RPL and control 
subjects (middle panel). Horizontal bars indicate the median expression in each group. (c) The
same transcripts were also measured in uteri of pregnant Sgk1–/– female mice crossed with WT
males (n=6) and WT females with Sgk1–/– males (n=6; right panel). Statistical significance was 
determined using students t-test and Mann Whitney U-test, * P < 0.05; ** P < 0.01; *** P <
0.001. Data are presented as means (± SEM).
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Supplementary Figure 12. Overexpression of catalase rescues decidualizing cells from 
oxidative cell death induced by SGK1 silencing. (a) Primary HESC cultures, first transfected as 
indicated, were decidualized with cAMP and MPA for 2, 4, or 8 d. The percentage of dead or 
dying cells (<2N; indicated within each figure on the left) and viable cells (G0/G1, S, and G2/M; 
indicated within each figure on the right) was determined by flow cytometry of ethanol-fixed 
propidium iodide-stained cells. (b) Summary of the results of 3 biological replicate experiments. 
The data are presented as fold-change (± S.D.) in the apoptotic cell fraction of decidualizing 
primary cultures transfected as indicated and compared to parallel cultures transfected with non 
targeting (NT) siRNA and pcDNA3.1. Statistical significance was determined using students t-
test, * P < 0.05.
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Supplementary Figure 13. SGK1 deficiency deregulates the expression of decidual markers in 
vitro and in vivo. (a) Expression of the decidual marker genes IGFBP1, TIMP3, and LEFTY-A
in primary HESCs first transfected with non targeting (NT) or SGK1 siRNA and then 
decidualized with cAMP and MPA for 72 h. Three independent primary cultures were subjected 
to RTQ-PCR analysis. The results denote mean (± SEM) expression. (b) Expression of the same 
decidual markers was also determined in undifferentiated HESCs (0 d) or cultures decidualized 
with cAMP and MPA for 8 d. A total of 12 primary cultures were established from RPL 
individuals and 11 from control subjects, as detailed in Supplementary Table 1. Horizontal bars 
indicate the median expression in each group. (Note: logarithmic y-axis). (c) The mouse
homologues were also measured in uteri of pregnant Sgk1–/– female mice crossed with WT 
males (n=6) and WT females with Sgk1–/– males (n=6). In addition, we measured the expression 
levels of Prl8a2, a mouse decidual marker gene related to human PRL and involved in safe-
guarding the feto-maternal interface against environmental stressors. Statistical significance was 
determined using students t-test and Mann Whitney U-test, * P < 0.05; ** P < 0.01; *** P <
0.001.
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Supplementary Figure 14. LEFTY-A regulates SGK1 expression and activation. (a) Timed
mid-secretory endometrial biopsies from RPL subjects (n=6), fertile controls (FER; n=7), or 
unexplained infertility (INF; n=7) were analyzed for the expression of LEFTY-2 transcripts 
using RTQ-PCR. Transcript levels were normalized to the housekeeping gene L19. (Note:
logarithmic scale). (b) Ishikawa cells were pulsed with recombinant LEFTY-A (5 ng ml-1) and 
total (t-) and phosphorylated (p-) SGK1 levels determined by Western blot analysis at the 
indicated time-points. (c) The expression of SGK1 transcripts was determined in parallel 
cultures, treated for 2 to 24 h recombinant LEFTY-A (5 ng/ml), by RTQ-PCR. Statistical 
significance was determined using students t-test, ** P < 0.01; *** P < 0.001.
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Supplementary Table 1: Human subject characteristics and culture details.
A. Samples used in Fig. 1a & b
RPL (n=9) Fertile (FER, n=9) Infertile (INF, n=9)
Age (years): 35.1 ± 2.9 34 ± 2.9 32.9 ± 4.1
Live births: 0.6 ± 0.7 2.5 ± 1.4* 0.2 ± 0.4
Miscarriages: 7.4 ± 6.1* 0.3 ± 0.5 0
The infertile group consisted of individuals with unexplained infertility. The data presented are 
mean ± standard deviation. * indicates P < 0.001.
B. Samples used in Fig. 1c
RPL (n=6) INF (n=6)
Age (years): 33.0 ± 5.9 36.2 ± 2.6
Miscarriages: 4.3 ± 1.5* 0
The infertile group consisted of individuals with unexplained infertility. The data presented are 
mean ± standard deviation. * indicates P < 0.001.
C. Samples used for time-course analysis for SGK1, GPX3, and SOD2 mRNA (Fig. 4d and 
Supplementary Fig. 9)
RPL (n=9) Control (n=11)
Age (years): 34.1 ± 3.6 33 ± 4.9
Miscarriages: 3.9 ± 1.2 0.1 ± 0.3*
Day of biopsy from LMP: 16.2 ± 7.9 17 ± 5.6
Days in culture 16.3 ± 4.1 16 ± 5.1
The control group consisted of individuals with male factor, peritoneal/tubal or unexplained 
infertility. The data presented are mean ± standard deviation. LMP = last menstrual period. * 
indicates P < 0.001.
D. Samples used for time-course analysis for TXN, PRDX2, and GLRX mRNA (Supplementary 
Fig. 9)
RPL (n=12) Control (n=12)
Age (years): 37.1 ± 4.8 35.3 ± 4.6
Miscarriages: 4.7 ± 2.1 0.5 ± 0.8*
Day of biopsy from LMP: 16.8 ± 7.2 18 ± 10
Days in culture 17.1 ± 4.3 16.2 ± 4.3
The control group consisted of individuals with male factor, peritoneal/tubal or unexplained 
infertility. The data presented are mean ± standard deviation. LMP = last menstrual period. * 
indicates P < 0.001.
E. Samples used for time-course analysis for IGFBP-1, LEFTY-A, and TIMP-3 mRNA 
(Supplementary Fig. 11)
RPL (n=12) Control (n=11)
Age (years) 37.4 ± 4.73 33.5 ±4. 6
Miscarriages 4.6 ± 2.0 0.3 ± 0.6
Day of biopsy from LMP 17.1 ± 11.6 13.4 ± 9.1
Days in culture 8.8 ± 3.8 8.6 ± 3.7
The infertile group consisted of individuals with male factor, tubal or unexplained infertility. 
The data presented are mean ± standard deviation. LMP = last menstrual period. 
* indicates P < 0.001.
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Supplementary Methods
Immunohistochemistry and morphometric analysis. In brief, we deparaffinized, rehydrated 
in graded concentrations of ethanol paraffin-embedded and formalin-fixed tissue sections. We 
blocked endogenous peroxidase activity by immersing the slides for 30 min in freshly prepared 
0.3% hydrogen peroxide (H2O2) in phosphate-buffered saline (PBS). We then washed the slides 
in PBS and pre-incubated samples in 1.5% non-immune goat serum in PBS for 30 min at room 
temperature. Primary antibodies were added overnight at 4 °C in a humidified chamber at the 
following dilutions: t-SGK1 (1:1,000; Millipore), p-SGK1 (Ser255/Thr256; 1:1,000, Millipore), 
CFTR (1:500; Cell Signalling), NEDD4-2 (1:4,000; Abcam), -ENaC (1:500; Sigma), eGFP 
(1:1,000; Invitrogen) or activated Caspase-3 (1:400; Cell Signalling). We omitted the primary 
antibody as a negative control. We visualized the staining using Vectastain Elite ABC rabbit 
IgG kit (Vector Laboratories). We further assessed cell death by DeadEnd Colorimetric TUNEL 
system (Promega), according to the manufacturer’s instructions. For morphometric analysis, we 
stained uterine sections with hematoxylin and eosin and viewed at  40 magnification. We 
measured the area of 50 randomly selected glands and 100 luminal epithelial cell nuclei using 
the PALM microscope software (Carl Zeiss).
Real-time quantitative (RTQ) PCR. We extracted total RNA from human endometrial stromal 
cells (HESC) cultures or tissue samples using Stat60 (Tel-Test) and evaluated the quality of the 
RNA using a Bioanalyzer 2100 (Agilent Technologies, Inc). After treatment with DNAseI 
(Invitrogen), we reverse transcribed equal amounts of total RNA (2 μg) with Superscript First-
Strand synthesis system for RT-PCR (Invitrogen) and used the resulting cDNA as template in
RTQ-PCR analysis. We designed gene-specific primer pairs by using the Primer3 software 
(sequences are available on request), and used L19 and Cyclophilin expression (representing
non-regulated human and mouse genes, respectively) to normalize for variances in input cDNA. 
We detected gene expression using JumpStart-SYBR Green (Sigma) and the ABI stepONE Plus 
sequence detection system (Applied Biosystems). Expression levels of the samples are 
expressed as arbitrary units (AU), 

  
 T method. All measurements were 
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performed in triplicate. Melting curve analysis and agarose gel electrophoresis confirmed 
amplification specificity.
Transient transfection and flow cytometry. We cultured HESCs in 6-well plates until 80% 
confluency. We then transfected HESCs using the calcium phosphate precipitation method with 
an expression vector encoding human catalyse (1 g), control plasmid (pcDNA3.1) or with 50 
nM of the following siRNA reagents: SGK1-siGENOME SMARTpool or siCONTROL Non 
Targeting (Dharmacon). Using parallel cultures we either harvested the cells in RIPA buffer for 
Western blot analysis, or we washed the cells in PBS and subsequently fixed them with ice-cold 
70% ethanol. We stained the genomic DNA with propidium iodide (10 g ml-1; Sigma), treated 
with ribonuclease-A (0.1 mg ml-1; Sigma) for 30 min, and subjected the samples to flow 
cytometry analysis (FACSCalibur; BD Biosciences). The degree of apoptosis in HESCs was 
evaluated by measuring the sub-G1 fraction (< 2N). Transfection studies were performed in 
triplicate and repeated at least three times.
Measurement of cellular oxidation and cell viability. We seeded HESCs into 96-well black 
plates with clear bases and cultured them in 10% DCC-FBS/DMEM until confluency. We first 
transfected HESCs with either siRNA-SGK1 or non targeting siRNA, then decidualized for 72 
h. To measure the cellular oxidation status, cultured HESCs were loaded with   -
dichlorofluorescin (DCF) for 30 min, and washed twice in PBS. We then took measurements
every 2 min before and after pulsing with 250 M H2O2 for a 30 min period using a fluorimeter 
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using CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (MTS; Promega) 
according to the manufacturers’ protocol.
